← Leaderboards
Michael Chopp
Healthone Alliance
$8,373,111
Attributed
$8,373,111
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$26,345,491 · 14
By mechanism
P01$20,040,718 · 7
R01$5,363,655 · 5
P50$941,118 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Stroke”
- Judith S Hochman · New York University School Of Medicine$100,533,713
- Joseph Paul Broderick · University Of Cincinnati$91,227,021
- Merit E Cudkowicz · Massachusetts General Hospital$58,780,575
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Marinella Temprosa · George Washington University$56,125,420
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,611,126
Research focus
StrokeNonhuman Therapy EvaluationPathway InteractionsNeurologicNerve InjuryMediatingDesignCellsBaseBrainFunctional OutcomesNervous System PhysiologyLaboratory RatNervous System DisorderPlasminogen ActivatorPlayStroke TherapyIn VivoStatistics /BiometryMolecularRecovery Of FunctionNeurological RecoveryResponseNervous System Trauma
Grant awards (55)
Vasculotide promotes cognitive improvement in rats with vascular dementia$376,250
R01 · FY2023 · AG · contact PI
Diabetic stroke cardiac dysfunction; treatment with CD133+Exosomes$461,609
R01 · FY2021 · HL · contact PI
Diabetic stroke cardiac dysfunction; treatment with CD133+Exosomes$461,609
R01 · FY2020 · HL · contact PI
miR-17-92 exosome treatment of stroke$324,844
R01 · FY2019 · NS · contact PI
miR-17-92 exosome treatment of stroke$324,844
R01 · FY2018 · NS · contact PI
miR-17-92 exosome treatment of stroke$324,844
R01 · FY2017 · NS · contact PI
miR-17-92 exosome treatment of stroke$324,844
R01 · FY2016 · NS · contact PI
miR-17-92 exosome treatment of stroke$324,844
R01 · FY2015 · NS · contact PI
MSCs Induce Brain Plasticity via tPA$291,315
R01 · FY2015 · AG · contact PI
MSCs Induce Brain Plasticity via tPA$300,325
R01 · FY2014 · AG · contact PI
MSCs Induce Brain Plasticity via tPA$283,807
R01 · FY2013 · AG · contact PI
MSCs Induce Brain Plasticity via tPA$300,325
R01 · FY2012 · AG · contact PI
Center for Stroke Research$953,762
P01 · FY2011 · NS · contact PI
MSCs Induce Brain Plasticity via tPA$300,325
R01 · FY2011 · AG · contact PI
Administration$63,639
P01 · FY2011 · NS · contact PI
Center for Stroke Research$953,927
P01 · FY2010 · NS · contact PI
Administration$63,638
P01 · FY2010 · NS · contact PI
Center for Stroke Research$935,669
P01 · FY2009 · NS · contact PI
Center for Stroke Research$131,850
P01 · FY2009 · NS · contact PI
Administration$62,410
P01 · FY2009 · NS · contact PI
Center for Stroke Research$908,585
P01 · FY2008 · NS · contact PI
Administration$60,593
P01 · FY2008 · NS · contact PI
Treatment of Neural Injury with MSCs$1,208,801
P01 · FY2007 · NS · contact PI
Center for Stroke Research$882,290
P50 · FY2007 · NS · contact PI
Core--Biostatistical$241,760
P01 · FY2007 · NS · contact PI
Administration$58,828
P50 · FY2007 · NS · contact PI
Treatment of Neural Injury with MSCs$1,216,163
P01 · FY2006 · NS · contact PI
Core--Biostatistical$249,085
P01 · FY2006 · NS · contact PI
Treatment of Neural Injury with MSCs$72,500
P01 · FY2006 · NS · contact PI
CENTER FOR STROKE RESEARCH$1,472,915
P01 · FY2005 · NS
Treatment of Neural Injury with MSCs$1,201,571
P01 · FY2005 · NS
Core--Biostatistical$240,314
P01 · FY2005 · NS
CENTER FOR STROKE RESEARCH$1,430,008
P01 · FY2004 · NS
Treatment of Neural Injury with MSCs$1,184,629
P01 · FY2004 · NS
Core--Biostatistical$236,925
P01 · FY2004 · NS
CENTER FOR STROKE RESEARCH$1,388,360
P01 · FY2003 · NS
Treatment of Neural Injury with MSCs$1,194,758
P01 · FY2003 · NS
Core--Biostatistical$238,951
P01 · FY2003 · NS
CENTER FOR STROKE RESEARCH$1,347,925
P01 · FY2002 · NS
ANTIICAM-1 AND RTPA TREATMENT OF EMBOLIC STROKE$329,566
R01 · FY2002 · NS
LIPOSOME AND BSO ENHANCEMENT OF PHOTODYNAMIC THERAPY$228,401
P01 · FY2002 · CA
CORE--BIOSTATISTICS$173,158
P01 · FY2002 · NS
ANTIPLATELET AGGREGATION THERAPY FOR EMBOLIC STROKE$173,158
P01 · FY2002 · NS
ANTIPLATELET AGGREGATION THERAPY FOR EMBOLIC STROKE$173,158
P01 · FY2002 · NS
CORE--BIOSTATISTICS$173,158
P01 · FY2002 · NS
CENTER FOR STROKE RESEARCH$110,069
P01 · FY2002 · NS
CENTER FOR STROKE RESEARCH$1,223,598
P01 · FY2001 · NS
ANTIICAM-1 AND RTPA TREATMENT OF EMBOLIC STROKE$321,618
R01 · FY2001 · NS
LIPOSOME AND BSO ENHANCEMENT OF PHOTODYNAMIC THERAPY$228,401
P01 · FY2001 · CA
CORE--BIOSTATISTICS$0
P01 · FY2001 · NS
ANTIPLATELET AGGREGATION THERAPY FOR EMBOLIC STROKE$0
P01 · FY2001 · NS
ANTIICAM-1 AND RTPA TREATMENT OF EMBOLIC STROKE IN RAT$312,686
R01 · FY2000 · NS
EVALUATION OF ANTI-ADHESION MOLECULE THERAPY AFTER MCA OCCLUSION IN THE RAT$173,158
P01 · FY2000 · NS
LIPOSOME AND BSO ENHANCEMENT OF PHOTODYNAMIC THERAPY$170,721
P01 · FY2000 · CA
CENTER FOR STROKE RESEARCH$155,000
P01 · FY2000 · NS